Sat, Apr 27, 2024
Volume 17, Issue 6 (Nov-Dec 2023)
mljgoums 2023, 17(6): 10-12 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Shahbazi A E, Barati N, Soleymani E, Khandan Del P, Khandan Del A, Azizi N, et al . Association between toxoplasmosis and COVID-19 infection: A cross-sectional study. mljgoums 2023; 17 (6) :10-12
URL: http://mlj.goums.ac.ir/article-1-1575-en.html
URL: http://mlj.goums.ac.ir/article-1-1575-en.html
Ali Ehsan Shahbazi1 
, Nastaran Barati2 , Eissa Soleymani3 , Pegah Khandan Del4 , Abolfazl Khandan Del5 , Nemat Azizi1 , Behjat Ranjouri1 , Mehran Bakhtiari3 , Seyedmousa Motavallihaghi 6
, Nastaran Barati2 , Eissa Soleymani3 , Pegah Khandan Del4 , Abolfazl Khandan Del5 , Nemat Azizi1 , Behjat Ranjouri1 , Mehran Bakhtiari3 , Seyedmousa Motavallihaghi 6
1- School of Nursing and Midwifery, Saveh University of Medical Sciences, Saveh, Iran
2- Research Center for Molecular Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
3- Department of Medical Parasitology and Mycology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
4- Department of Microbiology, Gorgan Branch, Islamic AzadUniversity, Gorgan, Iran
5- Department of Microbiology, 5th Azar Hospital, Golestan University of Hospital, Golestan University of Medical Sciences, Gorgan, Iran
6- Department of Medical Parasitology and Mycology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran , m_motevali@umsha.ac.ir
2- Research Center for Molecular Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
3- Department of Medical Parasitology and Mycology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
4- Department of Microbiology, Gorgan Branch, Islamic AzadUniversity, Gorgan, Iran
5- Department of Microbiology, 5th Azar Hospital, Golestan University of Hospital, Golestan University of Medical Sciences, Gorgan, Iran
6- Department of Medical Parasitology and Mycology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran , m_motevali@umsha.ac.ir
Abstract: (424 Views)
Background: COVID-19 is a respiratory disease pandemic and a major global health problem that can cause acute respiratory distress syndrome (ARDS). Previous studies have shown an inverse link between toxoplasmosis and COVID-19. This study aimed to evaluate the association between COVID-19 and toxoplasmosis infection.
Methods: In this cross-sectional descriptive study, samples were taken from 360 patients, 50% of whom were men and 50% were women. Of the patients, 180 were determined to be COVID-19-positive by the ELISA kit, and 180 were in the control group. Some demographic characteristics, such as sex, age range, and occupation, were also recorded.
Results: This study was conducted on 180 COVID-19-positive patients, of whom 26.7% were in the 16-30-year age group, 25.1% were self-employed, and 31.7% had anti-Toxoplasma gondii antibodies. Among the 180 control patients, 21.1% had antibodies for T. gondii. Of the 57 patients who were co-infected with both COVID-19 and toxoplasmosis, men had higher infection rates (63.2%) than women (36.8%). There was a significant relationship between co-infections with COVID-19 and toxoplasmosis with occupation, but not with age.
Conclusion: The study found that people with toxoplasmosis infection have a 1.73 times higher risk of contracting COVID-19. The findings suggest that infectious agents could be a predisposing factor, possibly due to changes in cytokine levels.
Methods: In this cross-sectional descriptive study, samples were taken from 360 patients, 50% of whom were men and 50% were women. Of the patients, 180 were determined to be COVID-19-positive by the ELISA kit, and 180 were in the control group. Some demographic characteristics, such as sex, age range, and occupation, were also recorded.
Results: This study was conducted on 180 COVID-19-positive patients, of whom 26.7% were in the 16-30-year age group, 25.1% were self-employed, and 31.7% had anti-Toxoplasma gondii antibodies. Among the 180 control patients, 21.1% had antibodies for T. gondii. Of the 57 patients who were co-infected with both COVID-19 and toxoplasmosis, men had higher infection rates (63.2%) than women (36.8%). There was a significant relationship between co-infections with COVID-19 and toxoplasmosis with occupation, but not with age.
Conclusion: The study found that people with toxoplasmosis infection have a 1.73 times higher risk of contracting COVID-19. The findings suggest that infectious agents could be a predisposing factor, possibly due to changes in cytokine levels.
Research Article: Research Article |
Subject:
Parasitology
Received: 2022/09/11 | Accepted: 2023/01/23 | Published: 2024/02/26 | ePublished: 2024/02/26
Received: 2022/09/11 | Accepted: 2023/01/23 | Published: 2024/02/26 | ePublished: 2024/02/26
References
1. Wang Y, Wang Y, Chen Y, Qin Q. Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID‐19) implicate special control measures. J Med Virol. 2020;92(6):568-76. [View at Publisher] [DOI] [PMID] [Google Scholar]
2. Cao W, Shi L, Chen L, Xu X, Wu Z. Clinical features and laboratory inspection of novel coronavirus pneumonia (COVID-19) in Xiangyang, Hubei. medRxiv. 2020. [View at Publisher] [DOI] [Google scholar] [Google Scholar]
3. Manesh RM, Safa AH, Sharafi SM, Jafari R, Bahadoran M, Yousefi M, et al. Parasites and chronic renal failure. J Renal Inj Prev. 2014;3(4):87-90. [View at Publisher] [DOI] [PMID] [Google scholar]
4. Russell B, Moss C, George G, Santaolalla A, Cope A, Papa S, et al. Associations between immune-suppressive and stimulating drugs and novel COVID-19-a systematic review of current evidence. Ecancermedicalscience. 2020;14:1022. [View at Publisher] [DOI] [PMID] [Google Scholar]
5. Slimano F, Baudouin A, Zerbit J, Toulemonde-Deldicque A, Thomas-Schoemann A, Chevrier R, et al. Cancer, immune suppression and Coronavirus Disease-19 (COVID-19): Need to manage drug safety (French Society for Oncology Pharmacy [SFPO] guidelines). Cancer treatment reviews. 2020;88. [View at Publisher] [DOI] [PMID] [Google Scholar]
6. Zadeh AE, Bamedi T, Etemadi S, Shahrakipour M, Saryazdipour K. Toxoplasmosis as a complication of transfusion in hemodialysis patients. Iran J Ped Hematol Oncol. 2014;4(1):22-5. [View at Publisher] [PMID] [Google Scholar]
7. Zhong J, Tang J, Ye C, Dong L. The immunology of COVID-19: is immune modulation an option for treatment? The Lancet Rheumatology. 2020;2(7):E428-36. [View at Publisher] [DOI] [PMID] [Google Scholar]
8. Jankowiak Ł, Rozsa L, Tryjanowski P, Møller AP. Strong negative covariation between toxoplasmosis and CoVID-19 at a global scale: a spurious indirect effect? 2020. [View at Publisher] [DOI] [Google Scholar]
9. Alavi SM, Alavi L. Toxoplasmosis in Iran: A guide for general physicians working in the Iranian health network setting: A systematic review. Caspian J Intern Med. 2016;7(4):233-41. [View at Publisher] [PMID] [Google Scholar]
10. Alghamdi J, Elamin MH, Alhabib S. Prevalence and genotyping of Toxoplasma gondii among Saudi pregnant women in Saudi Arabia. Saudi Pharm J. 2016;24(6):645-51. [View at Publisher] [DOI] [PMID] [Google Scholar]
11. Zeleke AJ, Melsew YA. Seroprevalence of Toxoplasma gondii and associated risk factors among HIV-infected women within reproductive age group at Mizan Aman General Hospital, Southwest Ethiopia: a cross sectional study. BMC Res Notes. 2017;10(1):70. [View at Publisher] [DOI] [PMID] [Google Scholar]
12. Maraghi S, Yadyad MJ, Sheikhi M, Shamakhteh F, Latifi SM. Study the anti-Toxoplasma antibodies (IgG and IgM) in hemodialysis patients of Abadan and Khoramshahr cities Southwest Iran in 2011 using ELISA. Jundishapur J Microb. 2013;6(7):e7113. [View at Publisher] [DOI] [Google Scholar]
13. Motevalli Haghi SM, Fakhar M, Sharif M, Keyghobadi M. An overview on different diagnostic methods for babesiosis. J Mazandaran Univ Med Sci. 2014;23(109):283-95. [View at Publisher] [Google Scholar]
14. Norouzi M, TABAEI SJS, Niyyati M, Saber V, Behniafar H. Genotyping of Toxoplasma gondii Strains Isolated from Patients with Ocular Toxoplasmosis in Iran. Iran J Parasitol. 2016;11(3):316-24. [View at Publisher] [PMID] [Google Scholar]
15. Motevalli Haghi SM, Najm M, Fakhar M, Gholami S, MotevalliHaghi S. Prevalence of Enterobius vermicularis infection among kindergartens of Sari and Babol cities during 2011. J Mazandaran Univ Med Sci. 2012;21(1):240-2. [View at Publisher] [Google Scholar]
16. Shen B, Yuan Y, Cheng J, Pan M, Xia N, Zhang W, et al. Activation of chronic toxoplasmosis by transportation stress in a mouse model. Oncotarget. 2016;7(52):87351-60. [View at Publisher] [DOI] [PMID] [Google Scholar]
17. Haghi MM, Khorshidvand Z, Khazaei S, Foroughi-Parvar F, Sarmadian H, Barati N, et al. Cryptosporidium animal species in Iran: a systematic review and meta-analysis. Trop Med Health. 2020;48(1):1-15. [View at Publisher] [DOI] [PMID] [Google Scholar]
18. Amany M, Eid R, Fahmy B. Biochemical studies on the effect of Toxoplasma infection on liver and kidney functions in mice. Egyptain Journal of Comparative Pathology and Clinical Pathology. 2010;23(1):174-85. [View at Publisher] [Google Scholar]
19. Gharavi M, Jalali S, Khademvatan S, Heydari S. Detection of IgM and IgG anti-Toxoplasma antibodies in renal transplant recipients using ELFA, ELISA and ISAGA methods: comparison of pre-and post-transplantation status. Ann Trop Med Parasitol. 2011;105(5):367-71. [View at Publisher] [DOI] [PMID] [Google Scholar]
20. Shahbazi AE, Saidijam M, Maghsood AH, Matini M, Haghi MM, Fallah M. Genotyping of fresh and Parafinized human hydatid cysts using nad1 and cox1 genes in Hamadan Province, west of Iran. Iran J Parasitol. 2020;15(2):259-65. [View at Publisher] [DOI] [PMID] [Google Scholar]
21. Rawson TM, Moore LS, Zhu N, Ranganathan N, Skolimowska K, Gilchrist M, et al. Bacterial and fungal coinfection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing. Clin Infect Dis. 2020;71(9):2459-68. [View at Publisher] [DOI] [PMID] [Google Scholar]
22. Chen X, Liao B, Cheng L, Peng X, Xu X, Li Y, et al. The microbial coinfection in COVID-19. Appl Microbiol Biotechnol. 2020;104(18):7777-85. [View at Publisher] [DOI] [PMID] [Google Scholar]
23. Ssebambulidde K, Segawa I, Abuga KM, Nakate V, Kayiira A, Ellis J, et al. Parasites and their protection against COVID-19-Ecology or Immunology? MedRxiv. 2020. [View at Publisher] [DOI] [Google Scholar]
24. Sharaf-El-Deen SA. Toxoplasma gondii as a possible risk factor for COVID-19 severity: a case-control study. Egypt J Med Microbiol. 2021;30(2):125-32. [View at Publisher] [DOI] [Google Scholar]
25. Chiappelli F, Khakshooy A, Greenberg G. CoViD-19 immunopathology and immunotherapy. Bioinformation. 2020;16(3):219-22. [View at Publisher] [DOI] [PMID] [Google Scholar]
26. De Biasi S, Meschiari M, Gibellini L, Bellinazzi C, Borella R, Fidanza L, et al. Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia. Nat Commun. 2020;11(1):3434. [View at Publisher] [DOI] [PMID] [Google Scholar]
27. Winkler F, Bengsch B. Use of mass cytometry to profile human T cell exhaustion. Front Immunol. 2020;10:3039. [View at Publisher] [DOI] [PMID] [Google Scholar]
28. Luo P, Liu Y, Qiu L, Liu X, Liu D, Li J. Tocilizumab treatment in COVID‐19: a single center experience. J med virol. 2020;92(7):814-8. [View at Publisher] [DOI] [PMID] [Google Scholar]
29. Dróżdż M, Krzyżek P, Dudek B, Makuch S, Janczura A, Paluch E. Current State of Knowledge about Role of Pets in Zoonotic Transmission of SARS-CoV-2. Viruses. 2021;13(6):1149. [View at Publisher] [DOI] [PMID] [Google Scholar]
30. Giraldo-Ramirez S, Rendon-Marin S, Jaimes JA, Martinez-Gutierrez M, Ruiz-Saenz J. SARS-CoV-2 clinical outcome in domestic and wild cats: A systematic review. Animals. 2021;11(7):2056. [View at Publisher] [DOI] [PMID] [Google Scholar]
31. Villanueva‐Saz S, Giner J, Tobajas AP, Pérez MD, González‐Ramírez AM, Macías‐León J, et al. Serological evidence of SARS‐CoV‐2 and co‐infections in stray cats in Spain. Transbound Emerg Dis. 2022;69(3):1056-64. [View at Publisher] [DOI] [PMID] [Google Scholar]
32. Michelitsch A, Schön J, Hoffmann D, Beer M, Wernike K. The Second Wave of SARS-CoV-2 Circulation-Antibody Detection in the Domestic Cat Population in Germany. Viruses. 2021;13(6):1009. [View at Publisher] [DOI] [PMID] [Google Scholar]
33. Flegr J. Toxoplasmosis is a risk factor for acquiring SARS-CoV-2 infection and a severe course of COVID-19 in the Czech and Slovak population: a preregistered exploratory internet cross-sectional study. Parasit Vectors. 2021;14(1):508. [View at Publisher] [DOI] [PMID] [Google Scholar]
34. Levin AT, Hanage WP, Owusu-Boaitey N, Cochran KB, Walsh SP, Meyerowitz-Katz G. Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications. Eur J Epidemiol. 2020;35(12):1123-38. [View at Publisher] [DOI] [PMID] [Google Scholar]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Enamad
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.